CD79A and melanoma: In melanoma patients treated with immunotherapy, clustering of plasma cells (mainly producing IgA and IgG) was associated with worse survival by an antigen-driven response that facilitated melanoma progression [10], and higher baseline serum IgG levels were associated with better overall survival [11].